<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1136777</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2023.1136777</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration</article-title>
<alt-title alt-title-type="left-running-head">Yang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2023.1136777">10.3389/fcell.2023.1136777</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1915807/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1701492/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Hang</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2177500/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Hai-Tao</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2241137/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chu</surname>
<given-names>Lei</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1641250/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Department of Orthopaedics</institution>, <institution>The Second Affiliated Hospital of Chongqing Medical University</institution>, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/314429/overview">Jiake Xu</ext-link>, University of Western Australia, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1840201/overview">Yu Song</ext-link>, Huazhong University of Science and Technology, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1389359/overview">Feng-Juan Lyu</ext-link>, South China University of Technology, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Lei Chu, <email>Chulei2380@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Molecular and Cellular Pathology, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1136777</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Yang, Lu, Zhou, Jiang and Chu.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Yang, Lu, Zhou, Jiang and Chu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Low back pain (LBP) is a prevalent health problem worldwide that affects over 80% of adults during their lifetime. Intervertebral disc degeneration (IDD) is a well-recognized leading cause of LBP. IDD is classified into five grades according to the Pfirrmann classification system. The purpose of this study was to identify potential biomarkers in different IDD grades through an integrated analysis of proteome sequencing (PRO-seq), bulk RNA sequencing (bRNA-seq) and single-cell RNA sequencing (scRNA-seq) data. Eight cases of grade I-IV IDD were obtained. Grades I and II were considered non-degenerative discs (relatively normal), whereas grades III and IV were considered degenerative discs. PRO-seq analysis was performed to identify differentially expressed proteins (DEPs) in various IDD grades. Variation analysis was performed on bRNA-seq data to differentiate expressed genes (DEGs) in normal and degenerated discs. In addition, scRNA-seq was performed to validate DEGs in degenerated and non-degenerated nucleus pulposus (NP). Machine learning (ML) algorithms were used to screen hub genes. The receiver operating characteristic (ROC) curve was used to validate the efficiency of the screened hub genes to predict IDD. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to analyze function enrichment and signaling pathways. Protein-protein interaction (PPI) network was used to prioritize disease-related proteins. SERPINA1, ORM2, FGG and COL1A1 were identified through PRO-seq as the hub proteins involved in regulating IDD. ML algorithms selected ten hub genes, including IBSP, COL6A2, MMP2, SERPINA1, ACAN, FBLN7, LAMB2, TTLL7, COL9A3, and THBS4 in bRNA-seq. Since serine protease inhibitor clade A member 1 (SERPINA1) was the only common gene, its accuracy in degenerated and non-degenerated NP cells was validated using scRNA-seq. Then, the rat degeneration model of caudal vertebra was established. The expression of SERPINA1 and ORM2 was detected using immunohistochemical staining of human and rat intervertebral discs. The results showed that SERPINA1 was poorly expressed in the degenerative group. We further explored the potential function of SERPINA1 by Gene Set Enrichment Analysis (GSEA) and cell-cell communication. Therefore, SERPINA1 can be used as a biomarker to regulate or predict the progress of disc degeneration.</p>
</abstract>
<kwd-group>
<kwd>bioinformatics</kwd>
<kwd>machine learning</kwd>
<kwd>bulk RNA sequencing</kwd>
<kwd>intervertebral disc degeneration</kwd>
<kwd>single-cell RNA sequencing</kwd>
<kwd>proteome sequencing</kwd>
</kwd-group>
<contract-num rid="cn001">cstc2021jcyj-msxmX0134</contract-num>
<contract-sponsor id="cn001">Natural Science Foundation of Chongqing<named-content content-type="fundref-id">10.13039/501100005230</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Low back pain (LBP) is a prevalent health problem worldwide that affects over 80% of adults during their lifetime (<xref ref-type="bibr" rid="B3">Cazzanelli and Wuertz-Kozak, 2020</xref>; <xref ref-type="bibr" rid="B1">Borenstein and Balagu&#xe9;, 2021</xref>). LBP has been the leading cause of disability in recent decades, especially in low- and middle-income countries (<xref ref-type="bibr" rid="B19">Hartvigsen et al., 2018</xref>). Intervertebral disc degeneration (IDD) is a major cause of LBP and the pathological basis of spinal diseases, such as spinal stenosis, radiculopathy, spur formation, lumbar disc herniation and lumbar vertebral instability (<xref ref-type="bibr" rid="B43">Wang et al., 2020</xref>). These diseases directly affect patients&#x2019; quality of life, and the treatment costs may be enormous for impoverished households (<xref ref-type="bibr" rid="B21">Hoy et al., 2012</xref>). An intervertebral disc (IVD), a fibrocartilage structure with great elasticity and tenacity, is located between two adjacent vertebrae. IVD is composed of the annulus fibrosus (AF), the inner nucleus pulposus (NP), and the cartilage endplate (CEP) on the superior and inferior sides of the disk (<xref ref-type="bibr" rid="B47">Yang et al., 2020</xref>). IVD can protect vertebral bones, the brain, and the spinal cord from internal and external shock and stress, as well as extend the range of motion of the spine (<xref ref-type="bibr" rid="B20">Hickman et al., 2022</xref>). In addition, IVD has a unique microenvironment characterized by mechanical loading, hypertonicity, hypoxia, nutrient deficiency, high acidity, and low cell density (<xref ref-type="bibr" rid="B35">Sakai and Grad, 2015</xref>). In a state of disequilibrium, a series of pathological changes occur in the IVD. NP cells are the inner core of the IVD. Therefore, during degeneration, several changes gradually occur in these cells, including cell reduction, increased apoptosis, decreased extracellular matrix (ECM) secretion, and increased expression of matrix degradation proteins (<xref ref-type="bibr" rid="B43">Wang et al., 2020</xref>). The degeneration of IVD is accompanied by the loss of proteoglycans and collagen fibers, eventually leading to a decrease in IVD height (<xref ref-type="bibr" rid="B35">Sakai and Grad, 2015</xref>). Magnetic resonance imaging is a highly sensitive method to detect IDD. IVD degeneration is classified into five grades according to the Pfirrmann classification system (<xref ref-type="bibr" rid="B33">Pfirrmann et al., 2001</xref>). With the rapid development of proteome sequencing (PRO-seq), bulk RNA sequencing (bRNA-seq) and single-cell RNA sequencing (scRNA-seq) technologies, multi-omics analysis has become a focal point of current research. Numerous studies have shown that proteins play a significant role in IDD (<xref ref-type="bibr" rid="B6">Cheng et al., 2018</xref>; <xref ref-type="bibr" rid="B5">Che et al., 2020</xref>; <xref ref-type="bibr" rid="B4">Chao-Yang et al., 2021</xref>). Messenger RNA is a type of RNA molecule that can transfer genetic information from DNA to ribosomes and serves as a template for protein synthesis (<xref ref-type="bibr" rid="B29">Morris et al., 2021</xref>). Studies have shown that several genes play an important role in the degenerative process of IDD, such as aggrecan, interleukin, and matrix metalloproteases (<xref ref-type="bibr" rid="B34">Roughley et al., 2006</xref>; <xref ref-type="bibr" rid="B42">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="B43">Wang et al., 2020</xref>). Previous bioinformatics studies identified candidate regulatory targets of IDD through RNA-seq analysis (<xref ref-type="bibr" rid="B25">Li et al., 2021</xref>). The scRNA-seq analysis identified a new group of chondrocytes in IDD and also proved the correlation between ferroptosis and IDD (<xref ref-type="bibr" rid="B49">Zhang et al., 2021b</xref>). Therefore, screening potential biomarkers of IDD <italic>via</italic> multi-omics analysis is of great clinical significance. Herein, we integrated three levels of omics analysis, including PRO-seq, bRNA-seq, and scRNA-seq, and performed tissue experiments using human and mice IVD tissues. IVD tissue samples with different degrees of degeneration (grades I-IV) were collected for PRO-seq analysis of the potential hub proteins in IDD, which were further revealed by bRNA-seq. scRNA-seq was performed to screen hub genes that effectively predict degenerating IVD disease. This study aimed to identify biomarkers that may reveal the mechanism of IDD and elucidate the potential therapeutic target of IDD.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 IVD tissue collection</title>
<p>Patients who underwent lumbar spine surgery at The Second Affiliated Hospital of Chongqing Medical University provided IVD tissue samples. According to the Pfirrmann classification system for disc degeneration, there was one case of grade I, one case of grade II, three cases of grade &#x2162; and three cases of grade &#x2163;. This study was approved by Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University, and informed consent was also obtained from patients before surgery.</p>
</sec>
<sec id="s2-2">
<title>2.2 PRO-seq analysis</title>
<p>PRO-seq was performed in human IVD NP tissue. Data acquisition was performed using the SCIEX TripleTOF 5600. <italic>p</italic>-values &#x3c;0.05 and &#x7c;log2 fold change) &#x7c; &#x3e; 1 were the cutoff criteria. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed using OmicsBean (<ext-link ext-link-type="uri" xlink:href="http://www.omicsbean.cn/">http://www.omicsbean.cn/</ext-link>). Protein-protein interaction (PPI) was conducted in STRING (<ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link>) using Cytoscape software (<ext-link ext-link-type="uri" xlink:href="https://cytoscape.org/">https://cytoscape.org/</ext-link>). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium <italic>via</italic> the PRIDE (<xref ref-type="bibr" rid="B32">Perez-Riverol et al., 2022</xref>) partner repository with the dataset identifier PXD040593.</p>
</sec>
<sec id="s2-3">
<title>2.3 bRNA-seq analysis</title>
<p>The Gene Expression Omnibus (GEO) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/">https://www.ncbi.nlm.nih.gov/gds/</ext-link>) was used to retrieve the bRNA-seq GSE70362 (<xref ref-type="bibr" rid="B23">Kazezian et al., 2015</xref>). Differentially expressed genes (DEGs) between grades were identified by analyzing bRNA-seq data with the &#x201c;limma&#x201d; package in R software (version 4.2.0). <italic>p</italic>-values &#x3c;0.05 and &#x7c;log2 FC&#x7c; &#x3e; 0.585 were the cutoff criteria. Machine learning (ML) methods consisted of the random forest (RF) classifier and support vector machine recursive feature elimination (SVM-RFE). The receiver operating characteristic (ROC) curve was analyzed using the R package &#x201c;pROC".</p>
</sec>
<sec id="s2-4">
<title>2.4 scRNA-seq analysis</title>
<p>GEO database entries for scRNA-seq GSE199866 (<xref ref-type="bibr" rid="B7">Cherif et al., 2022</xref>) and GSE205535 (<xref ref-type="bibr" rid="B26">Li et al., 2022</xref>) were downloaded. The R package Seurat (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/">https://satijalab.org/seurat/</ext-link>) was utilized to analyze scRNA-seq data. Using the &#x201c;tinyarray&#x201d; (<ext-link ext-link-type="uri" xlink:href="https://github.com/xjsun1221/tinyarray">https://github.com/xjsun1221/tinyarray</ext-link>) R package, the expression profiles were compared. The NP cells were annotated according to previews study (<xref ref-type="bibr" rid="B26">Li et al., 2022</xref>). The cell-cell communication analysis was conducted using &#x201c;CellChat&#x201d; R package.</p>
</sec>
<sec id="s2-5">
<title>2.5 Animal experiment</title>
<p>Ten male Sprague Dawley rats were obtained from the Animal Experiment Center of Chongqing Medical University. The rats were randomly divided into the normal control group and the degenerative group. In the degenerative group, a 20-gauge micropuncture needle was used to puncture the caudal vertebrae (Co) Co8-9. No treatment was performed in the normal control group. After 4&#xa0;weeks of treatment, Co8-9 IVDs of the two groups were removed, fixed with 4% paraformaldehyde, and decalcified. The Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University approved all animal experiments.</p>
</sec>
<sec id="s2-6">
<title>2.6 Hematoxylin and eosin staining</title>
<p>After 4&#xa0;weeks of decalcification with ethylenediaminetetraacetic acid (EDTA) (Solarbio, China), Co8-9 IVDs were embedded in paraffin. Following the manufacturer&#x2019;s instructions, paraffin-embedded tissue sections were sliced and stained with hematoxylin and eosin (Beyotime, China).</p>
</sec>
<sec id="s2-7">
<title>2.7 Immunohistochemical (IHC) staining</title>
<p>Protein expression was detected in different sections using the IHC kit (Zhongshan Jinqiao, China). IHC staining was performed on human and rat IVDs. Paraffin-embedded sections were routinely dewaxed, hydrated, and antigen repaired. The IHC kit was used to detect protein expression following the manufacturer&#x2019;s protocol. Subsequently, slices were blocked with goat serum and incubated with corresponding primary and secondary antibodies. Sections were stained with diaminobenzidine at room temperature for 40&#xa0;s and counterstained with hematoxylin for 30&#xa0;s. IVD tissue slices were dehydrated by ethanol gradients (50, 70, 90, and 100%). Finally, sections were photographed under an upright fluorescence microscope after being sealed with neutral balsam (Solarbio, China).</p>
</sec>
<sec id="s2-8">
<title>2.8 Gene Set Enrichment Analysis of SERPINC1</title>
<p>Gene Set Enrichment Analysis (GSEA) was performed to show the potential function of SERPINC1. The samples were classified into low- and high-SERPINC1 groups according to the median expression of SERPINC1. The related KEGG dataset was downloaded from MSigDB (<ext-link ext-link-type="uri" xlink:href="http://www.gsea-msigdb.org/gsea/downloads.jsp">http://www.gsea-msigdb.org/gsea/downloads.jsp</ext-link>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Identification of differentially expressed proteins (DEPs) in PRO-seq</title>
<p>DEPs between the grades of IVDs were analyzed using PRO-seq data. DEPs were selected based on cutoff criteria (&#x7c;log2 (fold change&#x7c; &#x3e; 1 and <italic>p</italic> &#x3c; 0.05). There were 35 high-expression and 62 low-expression proteins in grade III/I, 52 high-expression and 59 low-expression proteins in grade IV/I, 18 high-expression and 33 low-expression proteins in grade III/II, and 27 high-expression and 29 low-expression proteins in grade IV/II (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;D</xref>). Venn diagrams were drawn by taking the intersection of high-expression or low-expression proteins between groups. There were 17 high-expression proteins (<xref ref-type="fig" rid="F1">Figure 1E</xref>) and 43 low-expression proteins (<xref ref-type="fig" rid="F1">Figure 1F</xref>) in the intersection of III/I and IV/I, and 8 high-expression proteins (<xref ref-type="fig" rid="F1">Figure 1G</xref>) and 15 low-expression proteins (<xref ref-type="fig" rid="F1">Figure 1H</xref>) in the intersection of III/II and IV/II, respectively.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Differentially expressed proteins among different grades. <bold>(A)</bold> The DEPs of grade &#x2162; compared with grade I. <bold>(B)</bold> The DEPs of grade &#x2163; compared with grade I. <bold>(C)</bold> The DEPs of grade &#x2162; compared with grade II. <bold>(D)</bold> The DEPs of grade &#x2163; compared with grade II. <bold>(E)</bold> High expression differential proteins for &#x2162;/I and &#x2163;/I. <bold>(F)</bold> Low expression differential proteins for &#x2162;/I and &#x2163;/I. <bold>(G)</bold> High expression differential proteins for &#x2162;/II and &#x2163;/II. <bold>(H)</bold> Low expression differential proteins for &#x2162;/II and &#x2163;/II.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Functional enrichment analysis of DEPs in PRO-seq</title>
<p>GO, and KEGG enrichment analyses of DEPs were performed. The biological process, cell composition, and molecular function of DEPs between III/I, IV/I, III/II, and IV/II are shown in <xref ref-type="fig" rid="F2">Figures 2A&#x2013;D</xref>. The degree of DEP pathway enrichment between III/I, IV/I, III/II, and IV/II is shown in <xref ref-type="fig" rid="F2">Figures 2E&#x2013;H</xref>. Functional and pathway enrichment analyses revealed that the protein-encoding genes play multiple functions and involve multiple pathways in the degenerative process of IDD, indicating that IDD is a complex pathophysiological process.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The GO function analysis and KEGG signaling pathway analysis of DEPs. <bold>(A)</bold> GO function analysis for &#x2162;/I. <bold>(B)</bold> GO function analysis for &#x2163;/I. <bold>(C)</bold> GO function analysis for &#x2162;/II. <bold>(D)</bold> GO function analysis for &#x2163;/II. <bold>(E)</bold> KEGG signaling pathway analysis for &#x2162;/I. <bold>(F)</bold> KEGG signaling pathway analysis for &#x2163;/I. <bold>(G)</bold> KEGG signaling pathway analysis for &#x2162;/II. <bold>(H)</bold> KEGG signaling pathway analysis for &#x2163;/II.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 PPI network analysis of DEPs in PRO-seq</title>
<p>The correlation between proteins was analyzed by the PPI network. The top 10 core proteins were screened in III/I, IV/I, III/II, and IV/II groups. GAPDH, FGG, FGA, ENO1, C3, ACTB, VCAN, SERPINC1, SERPINA1, and ORM2 were core proteins in the III/I group. ACTB, TTR, AHSG, FGG, GC, HP, KNG1, ORM1, ORM2, and SERPINA1 were core proteins in the IV/I group. ACTB, SERPINA1, ORM2, and FGG were common proteins in the III/I and IV/I groups (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Among them, ACTB was removed due to its expression and interaction. COL6A3, COL6A2, COL6A1, COL2A1, COL1A1, ACTB, TUBB48, P4HB, LYZ, and HSPA5 were core proteins in the III/II group. CFB, C48, C3, AMBP, AHSG, A2M, KNG1, IGFBP5, CPB2, and COL1A1 were core proteins in the IV/II group. COL1A1 was the only common protein in the III/II and IV/II groups (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Protein-protein interaction <bold>(</bold>PPI) network analysis of DEPs. <bold>(A)</bold> Core proteins for &#x2162;/I and &#x2163;/I. <bold>(B)</bold> Core proteins for &#x2162;/II and &#x2163;/II.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 DEGs and functional enrichment of bRNA-seq</title>
<p>The IDD microarray dataset (GSE70362) was downloaded to explore the hub genes further. The bRNA-seq set was grouped according to the Thompson grading system (<xref ref-type="bibr" rid="B15">Gibson and Waddell, 2007</xref>). Grades I and II were considered the normal group, and grades III-V were the degenerated group. A total of 360 DEGs were screened between the two groups (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). GO and KEGG enrichment analyses were performed to determine the potential pathogenic mechanisms between the two groups (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). Among them, ECM-receptor interaction, also exhibited in the functional results of PRO-seq, was significant in the degenerative process of IDD (<xref ref-type="bibr" rid="B50">Zhang et al., 2021a</xref>). We calculated the correlation between DEGs and ECM-receptor interaction factors with <italic>p</italic> &#x3c; 0.001 and &#x7c;Cor-value&#x7c; &#x3e; 0.6. Nineteen ECM-receptor interaction-related genes (CGs) were identified (<xref ref-type="fig" rid="F4">Figure 4E</xref>). The PPI network of the CGs is shown in <xref ref-type="fig" rid="F4">Figure 4F</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Functional enrichment of bRNA-seq. <bold>(A, B)</bold> Volcano map and heatmap of the two groups in bRNA-seq. <bold>(C, D)</bold> Bar plot of GO and KEGG analysis. <bold>(E)</bold> Correlation maps between DEGs and ECM&#x2212;receptor interaction factors. <bold>(F)</bold> PPI network of the CGs.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Selection of optimal genes for IDD and efficiency validation in bRNA-seq</title>
<p>Two ML algorithms (RF and SVM-REF) were used to select candidate genes from CGs to predict IDD. RF and SVM-REF selected 13 genes each (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;E</xref>). With an intersection of 10 hub genes (IBSP, COL6A2, MMP2, SERPINA1, ACAN, FBLN7, LAMB2, TTLL7, COL9A3, and THBS4), RF and SVM-REF selected optimal hub genes for IDD (<xref ref-type="fig" rid="F5">Figure 5F</xref>). The ROC curve was used to estimate the predictiveness of the hub genes (<xref ref-type="fig" rid="F6">Figure 6</xref>). Among the ten hub genes, four genes had an area under the curve (AUC) &#x3e; 0.7, indicating predictive performance, and six genes had an AUC &#x3e;0.8, indicating the highly predictive ability of the hub genes.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Machine learning algorithms to select optimal genes of IDD in bRNA-seq. <bold>(A)</bold> The features of RF. <bold>(B, C)</bold> The index of SVM-REF. <bold>(D)</bold> Gene importance order of RF. <bold>(E)</bold> Average rank of genes in SVM-REF. <bold>(F)</bold> Venn diagram of the RF and SVM-REF results.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g005.tif"/>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Validation of hub genes predictiveness.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 scRNA-seq validation for SERPINA1</title>
<p>scRNA-seq analysis was performed to validate the expression of SERPINA1. After filtrating the appropriate value of genes (<xref ref-type="fig" rid="F7">Figure 7A</xref>), principal component analysis (PCA) and clustering analysis were performed. Data were divided into several PC clusters. The heatmap showed features of 1:15&#xa0;PC clusters (<xref ref-type="fig" rid="F7">Figure 7B</xref>). A uniform manifold approximation and projection (UMAP) was conducted for non-linear dimension reduction, and 17 clusters were obtained (<xref ref-type="fig" rid="F7">Figure 7C</xref>). The UMAP plot showed that healthy annulus fibrosus (AFH) and healthy nucleus pulposus (NPH) were relatively overlapping, while degenerated annulus fibrosus (AFD) and degenerated nucleus pulposus (NPD) were almost all overlapped (<xref ref-type="fig" rid="F7">Figure 7D</xref>). The expression of SERPINA1 was highly expressed in a large proportion of cells (<xref ref-type="fig" rid="F7">Figure 7E</xref>); however, the expression was much higher in the NPH compared with the NPD (<xref ref-type="fig" rid="F7">Figure 7F</xref>) but much lower in the AFH compared with the AFD (<xref ref-type="fig" rid="F7">Figure 7G</xref>). An external validation set that only contains NP cells was performed to check SERPINA1 expression in <xref ref-type="fig" rid="F7">Figure 7H</xref>.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>scRNA-seq level validation of SERPINA1. <bold>(A)</bold> Quality-control data of scRNA-seq. <bold>(B)</bold> 1:15 cluster of PCA reduction. <bold>(C)</bold> Dimplot of the 17 clusters after UMP reduction. <bold>(D)</bold> The distribution in Dimplot of AFH, NPH, AFD and NPD. <bold>(E)</bold> The expression and distribution of SERPINA1 in Dimplot. <bold>(F)</bold> The boxplot of SERPINA1&#x2032; expression comparison between NPD and NPH. <bold>(G)</bold> The boxplot of SERPINA1&#x2032; expression comparison between AFD and AFH. <bold>(H)</bold> The boxplot of SERPINA1&#x2032; expression comparison between NPD and NPH in the validation group.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g007.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 Protein expression in human IVDs and rat IVDs</title>
<p>To further examine the expression of core genes in IVD tissues, we performed IHC staining on human IVD tissues. Therefore, we detected the expression of ORM2 and SERPINA1 proteins in tissues, and the results showed that these expressions were higher in normal tissues than in degenerative tissues (<xref ref-type="fig" rid="F8">Figures 8A,B</xref>). At the same time, we also performed rat animal models of IDD and detected the changes in protein expression in rat IVD tissues. HE staining showed a normal structure of the annulus fibrosus, nucleus pulposus, and cartilage endplate, while the structure of the IVD was disordered in the degenerative group of rats (<xref ref-type="fig" rid="F8">Figure 8C</xref>). We also detected the expression of ORM2 and SERPINA1 proteins in rat IVD tissues. The results showed that the expression of ORM2 and SERPINA1 was higher in normal tissues than in degenerative tissues (<xref ref-type="fig" rid="F8">Figures 8D,E</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Protein expression in human IVDs and rat IVDs. <bold>(A)</bold> ORM2 expression in human IVDs. <bold>(B)</bold> SERPINA1 expression in human IVDs. <bold>(C)</bold> Hematoxylin and eosin staining of rat IVDs (AF, annulus fibrosus; NP, nucleus pulposus; CE, cartilage endplate). <bold>(D)</bold> ORM2 expression in rat IVDs. <bold>(E)</bold> SERPINA1 expression in rat IVDs.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g008.tif"/>
</fig>
</sec>
<sec id="s3-8">
<title>3.8 Functions of SERPINA1 in bRNA-seq</title>
<p>We performed GSEA analysis to explore how SERPINA1 could regulate IDD. SERPINA1 could activate ECM-receptor interaction and suppress peroxisomes (<xref ref-type="fig" rid="F9">Figure 9A</xref>). In addition, the ECM-receptor interaction was more enriched in the high-SERPINA1 group (<xref ref-type="fig" rid="F9">Figure 9B</xref>). In the comparison of the high-SERPINA1 group and low-SERPINA1 group, we found that APOPTOSIS and TGF&#x3b2; pathways exhibited higher performance in the low-SERPINA1 subtype and high-SERPINA1 respectively (<xref ref-type="fig" rid="F9">Figure 9C</xref>). Furthermore, SERPINA1 correlated significantly positively with MATURITY ONSET DIABETES OF THE YOUNG, but significantly negatively with GAP JUNCTION (<xref ref-type="fig" rid="F9">Figure 9D</xref>).</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Functions of SERPINA1 in bRNA-seq. <bold>(A)</bold> GSEA results of SERPINA1. <bold>(B)</bold> The enrichment status of SERPINA1 in ECM-receptor interaction pathway. <bold>(C)</bold> Boxplot of pathway enrichment differences in high-SERPINA1 group and low- SERPINA1 group. <bold>(D)</bold> The correlations between SERPINA1 and enriched pathways.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g009.tif"/>
</fig>
</sec>
<sec id="s3-9">
<title>3.9 Functions of SERPINA1 in scRNA-seq</title>
<p>NP cells of scRNA-seq data were reanalysed to investigate the function of SERPINA1 in different cell types. All NPD and NPH cells were grouped distinctively (<xref ref-type="fig" rid="F10">Figure 10A</xref>). According to the markers, the following types were identified: chondrocytes 1 (C1), chondrocytes 2 (C2), chondrocytes 3 (C3), chondrocytes 4 (C4), chondrocytes 5 (C5), neutrophil, and macrophage (<xref ref-type="fig" rid="F10">Figure 10B</xref>). SERPINA1 expressed sufficiently in C2 and C4 (<xref ref-type="fig" rid="F10">Figure 10C</xref>). C1 was almost exclusively composed of NPH cells, whereas C4 and C5 were almost exclusively composed of NPD cells. And there were no NPH cells in neutrophil and macrophage (<xref ref-type="fig" rid="F10">Figure 10D</xref>). The expressions of SERPINA1 in C1, C2, C3 and C4 were higher in the NPH subtype, and C5 had a lower expression of SERPINA1 in the NPH subtype (<xref ref-type="fig" rid="F10">Figure 10E</xref>). The numbers and weights of cell-cell communications were shown in <xref ref-type="fig" rid="F10">Figure 10F</xref>. In the cell types which expressed SERPINA1 highly in NPH, they had better performance in communicating with other cells (<xref ref-type="fig" rid="F10">Figure 10G</xref>). While the communication intensities of C5, macrophage, and neutrophil were relatively low (<xref ref-type="fig" rid="F10">Figure 10H</xref>). C5 and neutrophil had abundant communication probabilities in ANGPTL signaling network (<xref ref-type="fig" rid="F10">Figure 10I</xref>). The signaling network of COLLAGEN showed better strength in C1 and C3 (<xref ref-type="fig" rid="F10">Figure 10J</xref>).</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Functions of SERPINA1 in scRNA-seq. <bold>(A)</bold> NPH and NPD cells in scRNA-seq data. <bold>(B)</bold> Dimplot of cell types&#x2019; distributions. <bold>(C)</bold> Violin diagram of SERPINA1&#x2032; expression in different cell types. <bold>(D)</bold> The percentage of NPD and NPH in each cell type. <bold>(E)</bold> The comparison of SERPINA1&#x2032; expression in each cell type. <bold>(F)</bold> The interaction numbers and weights of cell-cell communications. <bold>(G)</bold> Cell-cell communications of C1, C2, C3 and C4. <bold>(H)</bold> Cell-cell communications of C5, neutrophil and macrophage. <bold>(I)</bold> Cell types participate in ANGPTL signaling network. <bold>(J)</bold> Cell types participate in COLLAGEN signaling network.</p>
</caption>
<graphic xlink:href="fcell-11-1136777-g010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>IDD is the most common cause of LBP (<xref ref-type="bibr" rid="B43">Wang et al., 2020</xref>). Pathophysiological changes associated with IDD are complex, and its degeneration mechanism is not entirely understood. IVD degeneration is an irreversible condition frequently linked to aging (<xref ref-type="bibr" rid="B12">Dowdell et al., 2017</xref>). Its clinical treatment mainly includes anti-inflammatory treatment and surgical resection or replacement of intervertebral discs (<xref ref-type="bibr" rid="B27">Mirza and Deyo, 2007</xref>). Nevertheless, these methods are only symptomatic treatments, and it is difficult to reverse the degenerative disc. The surgical treatment of intervertebral discs also burdens patients economically (<xref ref-type="bibr" rid="B14">Fiordalisi et al., 2021</xref>). Therefore, exploring the core genes and pathogenesis of intervertebral discs is essential, which may provide experimental and theoretical bases for the repair of IDD. In the present study, we performed multi-omics sequencing analyses in different IDD grades to identify the key hub genes and evaluate the function of the core hub genes. Five genes were identified (ACTB, COL1A1, SERPINA1, ORM2, and FGG) <italic>via</italic> PRO-seq by analyzing DEPs in different grades of human IVDs. Actin beta (ACTB) is a housekeeping gene and one of the cytoskeletal actins (<xref ref-type="bibr" rid="B9">Cuvertino et al., 2017</xref>). By analyzing data from gene microarrays (GSE23130) and microRNA expression microarrays (GSE63492), Mo et al. found that ACTB was highly expressed in degenerative tissues (<xref ref-type="bibr" rid="B28">Mo et al., 2019</xref>). Cui et al. found that ACTB was highly expressed in degeneration through sequencing the transcriptome of IVDs after one strike loading on the simulated disc degeneration of bovine (<xref ref-type="bibr" rid="B8">Cui et al., 2021</xref>). Actin gamma 1 (ACTG1), a member of the actin family, negatively correlates with the grades of human IDD (<xref ref-type="bibr" rid="B44">Wu et al., 2021a</xref>). F-actin cytoskeletal may also play a regulatory role in disc degeneration (<xref ref-type="bibr" rid="B24">Li et al., 2007</xref>). Cytoskeletal actin changes may affect the communication between cells and the extracellular matrix. During degeneration, the extracellular matrix of the intervertebral disc undergoes alterations, which are primarily manifested by the decrease in polysaccharide and collagen synthesis and the increase in decomposition (<xref ref-type="bibr" rid="B35">Sakai and Grad, 2015</xref>). The extracellular matrix of IVD is composed mainly of collagen, with type I collagen representing the primary constituent of the annulus fibrosus (<xref ref-type="bibr" rid="B47">Yang et al., 2020</xref>) and type II collagen serving as the main component secreted by nucleus pulposus cells (<xref ref-type="bibr" rid="B13">Fernandes et al., 2020</xref>). Correlative research demonstrated an association between collagen gene polymorphisms and IVD deterioration (<xref ref-type="bibr" rid="B40">Trefilova et al., 2021</xref>). Polymorphisms in COL1A1 Sp1 and COL11A1 C4603T are associated with IDD risk, and these collagen genes may be used to treat or prevent IDD (<xref ref-type="bibr" rid="B46">Xie et al., 2021</xref>). Fibrinogen, a non-collagen glycoprotein, is an important part of the extracellular matrix (<xref ref-type="bibr" rid="B36">Schuppan et al., 1998</xref>). The fibrinogen gamma chain (FGG) peptide was coated with adenosine diphosphate encapsulated liposomes, which played a hemostatic role in thrombocytopenic rabbits and caused lethal blast lung injury in mice (<xref ref-type="bibr" rid="B17">Hagisawa et al., 2016</xref>; <xref ref-type="bibr" rid="B18">Hagisawa et al., 2019</xref>). We found that the expression of FGG varied between degenerative and normal tissues. It may be used as a hub gene to regulate the IDD process. However, the effect of FGG on degenerative IVDs has not been observed, and further research is required to determine its role and specific mechanism in IVDs.</p>
<p>Further data exploration was conducted with bRNA-seq, and the functional enrichment analysis was performed based on the DEGs. GO analysis showed that collagen-containing extracellular matrix and glycosaminoglycan binding were enriched significantly. As a key structure in both the AF and NP of IVDs, changes in collagen content with degeneration indicate shifts from collagen type II to type I within the NP (<xref ref-type="bibr" rid="B48">Zeldin et al., 2020</xref>). Negatively charged aggrecan glycosaminoglycans can provide compressive stiffness, hydration, and swelling pressures to tissue, which leads to a high negative fixed charge density in NP (<xref ref-type="bibr" rid="B41">Wagner et al., 2020</xref>). KEGG analysis showed that the PI3K&#x2212;Akt signaling pathway and ECM-receptor interaction were enriched. We focused on the ECM-receptor interaction since ECM degradation is one of the leading causes of IDD (<xref ref-type="bibr" rid="B39">Sun et al., 2021</xref>). ML algorithms can be applied to analyze complex medical data and may guide clinical and nursing practice (<xref ref-type="bibr" rid="B11">Deo, 2015</xref>). Using ML methods, ten genes were selected, including IBSP, COL6A2, MMP2, SERPINA1, ACAN, FBLN7, LAMB2, TTLL7, COL9A3, and THBS4. COL6A2 is one type of collagen VI gene, a crucial component of the extracellular matrix. It forms a microfibrillar network closely associated with the cell and surrounding basement membrane (<xref ref-type="bibr" rid="B2">Bushby et al., 2014</xref>). It was reported that in the absence of the interleukin 1 beta T allele, the carriage of COL9A3 (Trp3 allele) increased the risk of dark nucleus pulposus (<xref ref-type="bibr" rid="B37">Solovieva et al., 2006</xref>). SERPINA1 was identified in both PRO-seq and bRNA-seq. We also explored the potential function of SERPINA1 in the bRNA-seq, with the expression variation of SERPINA1, the enrichments of the APOPTOSIS pathway, TGF&#x3b2; pathway, MATURITY ONSET DIABETES OF THE YOUNG pathway, and GAP JUNCTION pathway change as well. These pathways have already been proven to work in the process of IDD (<xref ref-type="bibr" rid="B16">Gruber et al., 2001</xref>; <xref ref-type="bibr" rid="B3">Cazzanelli and Wuertz-Kozak, 2020</xref>; <xref ref-type="bibr" rid="B45">Wu et al., 2021b</xref>). scRNA-seq has an advantage over bRNA-seq because it has an extracellular dimension. Further validation was thus performed in scRNA-seq, and the results showed that the expression of SERPINA1 was much higher in the normal group of NP tissue. In the different types of chondrocytes, C1, C2, C3, and C4 had higher SERPINA1 expressions in NPH compared with NPD, and they had better cell-cell communication intensities. But in C5, the expression of SERPINA1 was inverse, and the communication stayed in a low strength. Chondrocyte 4 (C4) is an inflamed chondrocyte (<xref ref-type="bibr" rid="B26">Li et al., 2022</xref>), and SERPINA1 expressed abundantly in C4. Although there were few NPH cells in C4, the expression of SERPINA1 was much greater in NPH compared with NPD. The underlying mechanisms are meaningful and worthy for our further exploring. Angiopoietin-like protein (ANGPTL) is structurally similar to angiopoietin, which facilitates the process of angiogenesis (<xref ref-type="bibr" rid="B30">Neto et al., 2019</xref>). And angiogenesis factor is involved in the development of IDD (<xref ref-type="bibr" rid="B10">David et al., 2010</xref>). With a high SERPINA1 expression in NPD, C5 performed well in the ANGPTL signaling network. Collagen is a part of NP, and its dysfunction occurs with IVD degeneration (<xref ref-type="bibr" rid="B40">Trefilova et al., 2021</xref>). C1 and C3 had higher SERPINA1 expressions in NPH, and their communications in COLLAGEN signaling network exhibited higher strength. Therefore, SERPINA1 was a pivotal gene for IDD.</p>
<p>Based on three structures, the nucleus pulposus, annulus fibrosus, and cartilage endplate in the normal intervertebral disc (<xref ref-type="bibr" rid="B47">Yang et al., 2020</xref>), we used a micropuncture needle to puncture the Co8-9 intervertebral disc of rats. The degenerative tissue contained a few nucleus pulposus cells, a damaged annulus fibrosus, and degenerative cartilage endplates (<xref ref-type="fig" rid="F8">Figure 8C</xref>). Degeneration destroys the structure of IVDs, affecting the internal balance of the disc. These results demonstrated that the model of degeneration in the caudal vertebra of rats was successfully established. We verified the expression of SERPINA1 in human and rat intervertebral discs using IHC staining. The expressions of SERPINA1 were lower in human and rat degenerating tissues than in normal tissues. SERPINA1 is a plasma protein and a serine protease inhibitor mainly expressed in the liver (<xref ref-type="bibr" rid="B31">Niemietz et al., 2020</xref>). A previous study showed that SERPINA1 peptides in urine could be used as potential markers for diagnosing the severity of preeclampsia (<xref ref-type="bibr" rid="B38">Starodubtseva et al., 2020</xref>). We also attempted to verify the expression of other hub genes in human and rat intervertebral discs. Interestingly, orosomucoid 2 (ORM2) expression was significantly higher in the normal NP compared with the degenerated counterpart. ORM (an acute phase protein) is a group of small molecule-binding proteins with immunomodulatory function (<xref ref-type="bibr" rid="B22">Jo et al., 2017</xref>). According to Zhu et al., high ORM2 expression was associated with a better prognosis in liver cancer patients (<xref ref-type="bibr" rid="B51">Zhu et al., 2020</xref>). However, there are few studies on ORM2 and SERPINA1 in IVDs.</p>
<p>In summary, we conclude that SERPINA1 is decreased in the NP tissue of IDD based on multi-omics analyses and experimental findings, suggesting that it could serve as a hub gene and a potential treatment target to regulate the process of IDD. The related pathway mechanism and target genes merit further investigation. This may provide a theoretical basis for reversing or repairing IDD in the future.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the ProteomeXchange Consortium, accession number PXD040593.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University. The patients/participants provided their written informed consent to participate in this study. The animal study was reviewed and approved by the Ethics Committee of The Second Affiliated Hospital of Chongqing Medical University.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>XY, YL, LC, HZ and H-TJ designed the study. XY, YL, LC, and H-TJ performed the experiment. XY, YL, LC, and HZ analyzed the data. XY, YL, and LC wrote the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This study was supported by the Natural Science Foundation of Chongqing (grant number cstc2021jcyj-msxmX0134).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borenstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Balagu&#xe9;</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Low back pain in adolescent and geriatric populations</article-title>. <source>Rheumatic Dis. Clin. N. Am.</source> <volume>47</volume> (<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.rdc.2020.12.001</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bushby</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Collagen type VI myopathies</article-title>. <source>Adv. Exp. Med. Biol.</source> <volume>802</volume>, <fpage>185</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-007-7893-1_12</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cazzanelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wuertz-Kozak</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>MicroRNAs in intervertebral disc degeneration, apoptosis, inflammation, and mechanobiology</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>10</issue>), <fpage>3601</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21103601</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao-Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hai-Hong</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Roles of NLRP3 inflammasome in intervertebral disc degeneration</article-title>. <source>Osteoarthr. Cartil.</source> <volume>29</volume> (<issue>6</issue>), <fpage>793</fpage>&#x2013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2021.02.204</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Che</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle</article-title>. <source>Elife</source> <volume>9</volume>, <fpage>e52570</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.52570</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein</article-title>. <source>Ann. Rheum. Dis.</source> <volume>77</volume> (<issue>5</issue>), <fpage>770</fpage>&#x2013;<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2017-212056</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherif</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mannarino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pacis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ragoussis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rabau</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ouellet</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Single-cell RNA-seq analysis of cells from degenerating and non-degenerating intervertebral discs from the same individual reveals new biomarkers for intervertebral disc degeneration</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>7</issue>), <fpage>3993</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23073993</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alini</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Transcriptional profiling of intervertebral disc in a post-traumatic early degeneration organ culture model</article-title>. <source>JOR spine</source> <volume>4</volume> (<issue>3</issue>), <fpage>e1146</fpage>. <pub-id pub-id-type="doi">10.1002/jsp2.1146</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuvertino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>ACTB loss-of-function mutations result in a pleiotropic developmental disorder</article-title>. <source>Am. J. Hum. Genet.</source> <volume>101</volume> (<issue>6</issue>), <fpage>1021</fpage>&#x2013;<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.11.006</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ciurea</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Iencean</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Angiogenesis in the degeneration of the lumbar intervertebral disc</article-title>. <source>J. Med. Life</source> <volume>3</volume> (<issue>2</issue>), <fpage>154</fpage>&#x2013;<lpage>161</lpage>.</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deo</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Machine learning in medicine</article-title>. <source>Circulation</source> <volume>132</volume> (<issue>20</issue>), <fpage>1920</fpage>&#x2013;<lpage>1930</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.115.001593</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dowdell</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Choma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vaccaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iatridis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Intervertebral disk degeneration and repair</article-title>. <source>Neurosurgery</source> <volume>80</volume>, <fpage>S46</fpage>&#x2013;<lpage>S54</lpage>. <pub-id pub-id-type="doi">10.1093/neuros/nyw078</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Trochez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diaz-Hernandez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Presciutti</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Single-cell RNA-seq identifies unique transcriptional landscapes of human nucleus pulposus and annulus fibrosus cells</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>15263</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-72261-7</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiordalisi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barbosa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Caldeira</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Intervertebral disc decellularisation: Progress and challenges</article-title>. <source>Eur. cells Mater.</source> <volume>42</volume>, <fpage>196</fpage>&#x2013;<lpage>219</lpage>. <pub-id pub-id-type="doi">10.22203/eCM.v042a15</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Waddell</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Surgical interventions for lumbar disc prolapse: Updated cochrane review</article-title>. <source>Spine</source> <volume>32</volume> (<issue>16</issue>), <fpage>1735</fpage>&#x2013;<lpage>1747</lpage>. <pub-id pub-id-type="doi">10.1097/BRS.0b013e3180bc2431</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruber</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hanley</surname>
<given-names>E. N.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Ingram</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>D. T.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Morphologic and molecular evidence for gap junctions and connexin 43 and 45 expression in annulus fibrosus cells from the human intervertebral disc</article-title>. <source>J. Orthop. Res.</source> <volume>19</volume> (<issue>5</issue>), <fpage>985</fpage>&#x2013;<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1016/S0736-0266(00)00072-3</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagisawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyawaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeoka</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Fibrinogen &#x3b3;-chain peptide-coated adenosine 5&#x27; diphosphate-encapsulated liposomes rescue mice from lethal blast lung injury via adenosine signaling</article-title>. <source>Crit. care Med.</source> <volume>44</volume> (<issue>9</issue>), <fpage>e827</fpage>&#x2013;<lpage>e837</lpage>. <pub-id pub-id-type="doi">10.1097/ccm.0000000000001707</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagisawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeoka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Combination therapy using fibrinogen &#x3b3;-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits</article-title>. <source>Transfusion</source> <volume>59</volume> (<issue>10</issue>), <fpage>3186</fpage>&#x2013;<lpage>3196</lpage>. <pub-id pub-id-type="doi">10.1111/trf.15427</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartvigsen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hancock</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kongsted</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Louw</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Genevay</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>What low back pain is and why we need to pay attention</article-title>. <source>Lancet (London, Engl.</source> <volume>391</volume> (<issue>10137</issue>), <fpage>2356</fpage>&#x2013;<lpage>2367</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(18)30480-x</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hickman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rathan-Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peck</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Development, pathogenesis, and regeneration of the intervertebral disc: Current and future insights spanning traditional to omics methods</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>10</volume>, <fpage>841831</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2022.841831</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bain</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>March</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Blyth</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>A systematic review of the global prevalence of low back pain</article-title>. <source>Arthritis rheumatism</source> <volume>64</volume> (<issue>6</issue>), <fpage>2028</fpage>&#x2013;<lpage>2037</lpage>. <pub-id pub-id-type="doi">10.1002/art.34347</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Suk</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Astrocytic orosomucoid-2 modulates microglial activation and neuroinflammation</article-title>. <source>J. Soc. Neurosci.</source> <volume>37</volume> (<issue>11</issue>), <fpage>2878</fpage>&#x2013;<lpage>2894</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2534-16.2017</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazezian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gawri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haglund</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ouellet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mwale</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tarrant</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Gene expression profiling identifies interferon signalling molecules and IGFBP3 in human degenerative annulus fibrosus</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>15662</fpage>. <pub-id pub-id-type="doi">10.1038/srep15662</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Duance</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Blain</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>F-actin cytoskeletal organization in intervertebral disc health and disease</article-title>. <source>Biochem. Soc. Trans.</source> <volume>35</volume>, <fpage>683</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1042/bst0350683</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Identification of circ-FAM169A sponges miR-583 involved in the regulation of intervertebral disc degeneration</article-title>. <source>J. Orthop. Transl.</source> <volume>26</volume>, <fpage>121</fpage>&#x2013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2020.07.007</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Single-cell RNA sequencing reveals the difference in human normal and degenerative nucleus pulposus tissue profiles and cellular interactions</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>10</volume>, <fpage>910626</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2022.910626</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deyo</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Systematic review of randomized trials comparing lumbar fusion surgery to nonoperative care for treatment of chronic back pain</article-title>. <source>Spine</source> <volume>32</volume> (<issue>7</issue>), <fpage>816</fpage>&#x2013;<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1097/01.brs.0000259225.37454.38</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>KEGG-expressed genes and pathways in intervertebral disc degeneration: Protocol for a systematic review and data mining</article-title>. <source>Medicine</source> <volume>98</volume> (<issue>21</issue>), <fpage>e15796</fpage>. <pub-id pub-id-type="doi">10.1097/md.0000000000015796</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cluet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ricci</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Ribosome dynamics and mRNA turnover, a complex relationship under constant cellular scrutiny</article-title>. <source>Wiley Interdiscip. Rev. RNA</source> <volume>12</volume> (<issue>6</issue>), <fpage>e1658</fpage>. <pub-id pub-id-type="doi">10.1002/wrna.1658</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neto</surname>
<given-names>N. I. P.</given-names>
</name>
<name>
<surname>Boldarine</surname>
<given-names>V. T.</given-names>
</name>
<name>
<surname>Hachul</surname>
<given-names>A. C. L.</given-names>
</name>
<name>
<surname>Oyama</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>E. S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients</article-title>. <source>Oncotarget</source> <volume>10</volume> (<issue>60</issue>), <fpage>6444</fpage>&#x2013;<lpage>6455</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.27269</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niemietz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bezerra</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Monia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Saraiva</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>SERPINA1 modulates expression of amyloidogenic transthyretin</article-title>. <source>Exp. Cell Res.</source> <volume>395</volume> (<issue>2</issue>), <fpage>112217</fpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2020.112217</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Riverol</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bandla</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Garcia-Seisdedos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hewapathirana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kamatchinathan</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume> (<issue>1</issue>), <fpage>D543</fpage>&#x2013;<lpage>D552</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab1038</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfirrmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Metzdorf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zanetti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hodler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boos</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Magnetic resonance classification of lumbar intervertebral disc degeneration</article-title>. <source>Spine</source> <volume>26</volume> (<issue>17</issue>), <fpage>1873</fpage>&#x2013;<lpage>1878</lpage>. <pub-id pub-id-type="doi">10.1097/00007632-200109010-00011</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roughley</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rantakokko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mwale</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Antoniou</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage</article-title>. <source>Eur. cells Mater.</source> <volume>11</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.22203/ecm.v010a01</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Grad</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Advancing the cellular and molecular therapy for intervertebral disc disease</article-title>. <source>Adv. drug Deliv. Rev.</source> <volume>84</volume>, <fpage>159</fpage>&#x2013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2014.06.009</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schuppan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Somasundaram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ackermann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ruehl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Collagens in the liver extracellular matrix bind hepatocyte growth factor</article-title>. <source>Gastroenterology</source> <volume>114</volume> (<issue>1</issue>), <fpage>139</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/s0016-5085(98)70642-0</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solovieva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lohiniva</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leino-Arjas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Raininko</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luoma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ala-Kokko</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms</article-title>. <source>Eur. spine J.</source> <volume>15</volume> (<issue>5</issue>), <fpage>613</fpage>&#x2013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-005-0988-1</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starodubtseva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nizyaeva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Baev</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bugrova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gapaeva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muminova</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>SERPINA1 peptides in urine as A potential marker of preeclampsia severity</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>3</issue>), <fpage>914</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21030914</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitophagy in degenerative joint diseases</article-title>. <source>Autophagy</source> <volume>17</volume> (<issue>9</issue>), <fpage>2082</fpage>&#x2013;<lpage>2092</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2020.1822097</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trefilova</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Shnayder</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Petrova</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Kaskaeva</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Tutynina</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Petrov</surname>
<given-names>K. V.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The role of polymorphisms in collagen-encoding genes in intervertebral disc degeneration</article-title>. <source>Biomolecules</source> <volume>11</volume> (<issue>9</issue>), <fpage>1279</fpage>. <pub-id pub-id-type="doi">10.3390/biom11091279</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Vedadghavami</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Goel</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Chahine</surname>
<given-names>N. O.</given-names>
</name>
<name>
<surname>Bajpayee</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Avidin grafted dextran nanostructure enables a month-long intra-discal retention</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>12017</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-68351-1</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>MMPs and ADAMTSs in intervertebral disc degeneration</article-title>. <source>Clin. chimica acta; Int. J. Clin. Chem.</source> <volume>448</volume>, <fpage>238</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2015.06.023</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The role of IL-1&#x3b2; and TNF-&#x3b1; in intervertebral disc degeneration</article-title>. <source>Biomed. Pharmacother. &#x3d; Biomedecine Pharmacother.</source> <volume>131</volume>, <fpage>110660</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110660</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>ACTG1 regulates intervertebral disc degeneration via the NF-&#x3ba;B-p65 and Akt pathways</article-title>. <source>Biochem. biophysical Res. Commun.</source> <volume>545</volume>, <fpage>54</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2021.01.057</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Kruppel like factor 10 prevents intervertebral disc degeneration via TGF-beta signaling pathway both <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>J. Orthop. Transl.</source> <volume>29</volume>, <fpage>19</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.jot.2021.04.003</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Association between polymorphisms of collagen genes and susceptibility to intervertebral disc degeneration: A meta-analysis</article-title>. <source>J. Orthop. Surg. Res.</source> <volume>16</volume> (<issue>1</issue>), <fpage>616</fpage>. <pub-id pub-id-type="doi">10.1186/s13018-021-02724-8</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Intervertebral disc ageing and degeneration: The antiapoptotic effect of oestrogen</article-title>. <source>Ageing Res. Rev.</source> <volume>57</volume>, <fpage>100978</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2019.100978</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeldin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mosley</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Laudier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gallate</surname>
<given-names>Z. S.</given-names>
</name>
<name>
<surname>Gansau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hoy</surname>
<given-names>R. C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Spatial mapping of collagen content and structure in human intervertebral disk degeneration</article-title>. <source>JOR Spine</source> <volume>3</volume> (<issue>4</issue>), <fpage>e1129</fpage>. <pub-id pub-id-type="doi">10.1002/jsp2.1129</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Single-cell RNA-seq analysis identifies unique chondrocyte subsets and reveals involvement of ferroptosis in human intervertebral disc degeneration</article-title>. <source>Osteoarthr. Cartil.</source> <volume>29</volume> (<issue>9</issue>), <fpage>1324</fpage>&#x2013;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2021.06.010</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>NF-&#x3ba;B signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration</article-title>. <source>Cell Prolif.</source> <volume>54</volume> (<issue>7</issue>), <fpage>e13057</fpage>. <pub-id pub-id-type="doi">10.1111/cpr.13057</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer</article-title>. <source>World J. gastroenterology</source> <volume>26</volume> (<issue>8</issue>), <fpage>804</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v26.i8.804</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>